Sage Journals: Discover world-class research

Abstract

Asylum-seekers and refugees have an increased burden of infections compared with the general population. This has been widely recognised by countries welcoming those fleeing conflict and persecution; however, there are no screening standardised guidelines and regulatory processes. Identification of certain neglected tropical diseases (NTDs) and other infections is important for the health and well-being of the individual in addition to public health and biosecurity. In the United Kingdom, screening for infections at port of entry or after arrival is not mandatory. Those on refugee resettlement programmes will have infection screening as part of their pre-entry health assessment, but no such system exists for those claiming asylum in the United Kingdom. In this article, we have reviewed published, peer-reviewed articles looking at the approaches to screening for NTDs and infectious diseases in the United Kingdom. In addition to this, we have reviewed the literature looking at the acceptability, barriers and facilitators of these screening practices. We found that there is a heterogeneous approach to screening practices in the United Kingdom and a paucity of data to support a single ‘best practice’ approach. Based on our findings, we have made recommendations and consideration for NTD screening strategies and highlighted important areas for future research.

Keywords

asylum-seekers communicable diseases neglected tropical diseases refugees screening

Introduction

Background

Migration is inextricably connected to human history. Some people leave their homes to seek employment, travel and meaningful lives in another country. Others are forced to do so because they face persecution, conflict or natural disaster if they stay. As global migration has increased,¹ so too has forced migration due to the exacerbation of several crises in the last 10 years.² The number of people seeking asylum or entering the United Kingdom as refugees has increased steadily over the last decade.³ In 2021, the number of people applying for asylum in the United Kingdom reached 48,540, the highest number for almost two decades.⁴

Migrants, and especially forced migrants (definitions in Table 1), might be at higher risk of infectious diseases for many reasons. They have an increased risk of exposure to many pathogens due to higher prevalence in their country of origin, poor living conditions during the journey and in destination countries.

Table 1.

Definitions.

Migrant	Someone who moves from his or her country of usual residence, regardless of the reason for migration or legal status.
Forced migrant	A person subject to a migratory movement in which an element of coercion exists, including threats to life and livelihood, whether arising from natural or man-made causes (e.g. movements of refugees and internally displaced persons as well as people displaced by natural or environmental disasters, chemical or nuclear disasters, famine or development projects).
Asylum-seeker	Individual who is seeking international protection, has applied for asylum and is awaiting a decision on their asylum application.
Refugee	A person who has been granted asylum under national legislation.
Refused asylum-seeker	A person whose asylum application has been unsuccessful and who has no other claim for protection awaiting a decision. Some refused asylum-seekers voluntarily return home, others are forcibly returned. For some, it is not safe or practical to return until conditions in their country change.
Resettled Refugee	A person who has been granted refugee status or another form of humanitarian protection by the United Kingdom while abroad and then brought to live in the United Kingdom.
Unaccompanied asylum-seeking children (UASC)	A person under 18 who is applying for asylum in the United Kingdom in their own right, is separated from both parents, and is not being cared for by a relative or guardian in the United Kingdom.

UNHCR, United Nations High Commissioner for Refugees.

The definition of asylum-seekers, refugee and migrant are from the UNHCR Master Glossary of Terms (https://www.unhcr.org/glossary/). The definition of forced migrant is from the IOM Glossary of Migration 2019 (https://publications.iom.int/system/files/pdf/iml_34_glossary.pdf). The definition of refused asylum-seeker comes from the Refugee Council (https://www.refugeecouncil.org.uk/information/refugee-asylum-facts/the-truth-about-asylum/). The definition of resettled refugee and UASC are UK-specific and comes from the gov.uk website.

Access to diagnosis and treatment is often limited due to the disruption of the infrastructure in the country of origin; barriers to accessing healthcare are language, stigma, awareness of entitlement, and limited provision of services. In addition to this, frequent relocations between countries and areas within countries pose further challenges to healthcare provision.

Neglected tropical diseases and infectious diseases

Neglected tropical diseases (NTDs) is an umbrella term encompassing 20 communicable diseases.⁵ They are described as being ‘neglected’ due to a paucity of research and treatment options.⁶ These medical conditions are often endemic in many low- and middle-income countries and affect almost 2 billion people globally. In the United Kingdom, NTDs are usually identified as imported cases, with statistics available only for three of them.⁷ The UK Health Security Agency (UKHSA) has published data on chikungunya and dengue infections occurred in 2014 (347 cases of dengue⁸ and 295 cases of Chikungunya⁹). Rabies is monitored annually and all cases occurring since 1902 were imported, with the last one occurred in 2018.¹⁰

NTDs are often asymptomatic or produce only mild symptoms in early stages of infection. Some NTDs can lead to vertical transmission, and most can be either prevented or treated with public health interventions, screening or early diagnosis. If left untreated, many can result in severe morbidity and mortality such as increased risk of malignancy and end organ damage in later life. Previous studies have demonstrated that asylum-seekers and refugees are more likely to be affected by NTDs such as Chagas disease, schistosomiasis, and filariasis.^11,12

This population also has a higher prevalence of infectious diseases such as tuberculosis (TB), human immunodeficiency virus (HIV), hepatitis B, as well as malaria and enteric fevers.^13,14

Screening

Screening of infectious diseases in migrant populations has gained considerable attention over the last few decades. In the United Kingdom, and many other European countries, screening practices have been largely targeted towards TB, with a focus on biosecurity and the protection of public health.¹⁵

The first systematic screening programme for infection in migrants, in the United Kingdom, was introduced in 1965 and involved port-of-entry screening for TB with chest radiographs.^16–18 Since 2012, those seeking asylum or refuge in the United Kingdom through formal routes (i.e. through refugee resettlement programmes) undergo pre-entry screening for TB, blood-borne infections (BBI); HIV and hepatitis B and C, syphilis and other sexually transmitted infections (STIs), intestinal helminths and malaria before coming to the United Kingdom.^19,20

The majority of asylum-seekers do not travel through formal routes and are therefore not screened prior to entry to the United Kingdom. There is currently no statutory requirement to have an initial health assessment or screening for infectious diseases for this population. The UKHSA and the Royal College of Paediatrics and Child Health (RCPCH) have published guidelines to support the holistic assessment and screening of this population at any opportunistic healthcare encounter.^21,22 The recommendations are summarised in Table 2.

Table 2.

Summary of the UKHSA migrant health guide.

Infection	Basis for testing	Method of testing
Latent tuberculosis	• From a country of TB incidence > 40 cases per 100,000 • Coming to work or settle in the United Kingdom	IGRA
HIV	• All adults and children from a country of HIV prevalence > 1%	Ab/Ag on serum
Hepatitis B	• All adults and children from a country with a hepatitis B prevalence > 2%	HbSAg, anti-HBc Ab
Hepatitis C	• All adults and children from a country with ‘high’ hepatitis C prevalence – Africa, Asia, the Caribbean, Central and South America, Eastern and Southern Europe, the Middle East, the Pacific Islands	Hepatitis C serology
Helminth infection (Strongyloides stercolaris, Schistosoma species, Ascaris lumbricoides (roundworm), Necator Americanus (hookworm) and Trichuris trichuria (whipworm)	• Unexplained gastrointestinal symptoms • Eosinophilia > 0.4 × 10⁹ • If anaemic to consider hookworm	Stool microscopy Strongyloides serology If from Sub-Saharan Africa: urine microscopy test and Schistosoma serology
Lymphatic filariasis, Loiasis and Onchocerciasis	Consider if eosinophilia > 0.4 × 10⁹ but rarely encountered in general practice
Sexually transmitted infections	• All sexually active people from a country with an HIV prevalence > 1%• All sexually active people whose sexual history warrants testing• All sexually active people < 25 years, annual testing for Chlamydia	Recommended through GUM clinics

Ab, antibodies; Ag, antigen; anti-HBc, antibodies to hepatitis B core antigen; GUM, genito-urinary medicine; HbSAg, hepatitis B surface antigen; HIV, human immunodeficiency virus; IGRA, interferon gamma release assay; TB, tuberculosis; UKHSA, UK Health Security Agency.

Indiscriminate NTDs screening is not currently recommended by these guidelines; however, investigations for helminth infections, lymphatic filariasis, loiasis and onchocerciasis are suggested if there is a positive history of exposure or eosinophilia is picked up on routine full blood count (FBC) test.

This article reviews the existing literature regarding the approaches to screening for infectious diseases and NTDs in asylum-seekers, refugees and newly arrived migrants in the United Kingdom, and it provides recommendations on how to implement this practice.

Methods

We have searched three databases – MEDLINE, Embase and Global Health – with no time restriction. We used a Boolean search strategy combining keywords and MesH term around three main concepts: ‘asylum-seekers’ or ‘refugees’ and ‘infectious diseases’ and ‘screening’. We restricted the result to studies conducted in the United Kingdom. (Search strategy and details of the methods used are available in Supplementary Materials.)

As the terms ‘refugees’, ‘asylum-seekers’ and ‘migrants’ are sometimes used interchangeably, we have used all the synonyms to avoid omitting studies.

The main objectives of the review are:

To investigate the approaches to infectious diseases and NTDs screening of refugees and asylum-seekers in the United Kingdom;

To explore acceptability, barriers and facilitators of screening practices;

To explore the attitude of healthcare workers towards screening migrants for infectious diseases and NTDs.

We included both qualitative and quantitative studies which described a screening intervention on the target population. We have defined our target population as refugees or asylum-seekers or newly arrived migrants (where newly arrived were defined as arrived in the United Kingdom in the last 5 years). We excluded studies that did not describe a screening intervention or did not focus on our target population. We did not include ‘grey literature’ (i.e. not published in journals or books, not peer-reviewed articles) in our review.

Data were extracted using a form including the following variables: characteristic of the study design, location, screening strategy and screening settings, numbers screened, infection screened and outcomes. For the qualitative studies, the main themes have been grouped in these categories: acceptability, barriers and facilitators in access to care, and attitudes of healthcare workers.

Results

The original search found 110 papers, of which 46 were excluded on the basis of the title and abstract. The full text of 64 articles was analysed, and another 5 articles were identified from Snowball Reference. Twenty articles were included in the literature review, of which 13 were quantitative studies, 6 qualitative and 1 mixed methods (see Figure 1).

Figure 1.

Literature review flow chart.

Quantitative studies and mixed methods

Fourteen studies were included in the quantitative analysis, of which one was a mixed method study. Nine studies described a retrospective methodology, with four identified as retrospective cohort study and five as retrospective audit or data analysis. Four studies had a cross-sectional design. The mixed-method study used a retrospective design for the analysis of the quantitative data.

Target population

The target population in the studies was diverse. Only three studies focused on asylum-seekers: one on the adult population,²³ one on unaccompanied asylum-seeking children (UASC)²⁴ and one on accompanied asylum-seeking children.²⁵ One study focused on refugees arriving in the United Kingdom through a governmental resettlement programme.¹³ Out of the remaining 10 studies, 7 focused on migrants that are described as ‘newly arrived’^26–32 and 3 retrospective studies focusing on migrants living in specific locations in the 5 years preceding the analysis.^33–35 (Summary tables of the studies included are available in Supplementary Materials.)

Screening strategies

Studies that included NTD screening. Only two studies described a broad approach to screening for infectious diseases including NTDs. Both were cross-sectional studies of specialist paediatric clinics for asylum-seeking children. Harkensee and Andrew²⁵ screened accompanied asylum-seeking children for infectious diseases based on risk of exposure in country of origin and countries of transit. Children were screened for Latent TB Infection (LTBI), BBI, malaria, strongyloidiasis, schistosomiasis and eosinophilia, which was used as a proxy for parasitic infections. Williams et al.²⁴ screened UASC in their paediatric infectious diseases clinics in London. The screening was voluntary, offering universal testing to all UASC using a panel-based approach for LTBI, BBI and STIs. All children had an FBC, urine dip and stool for parasitological examination. Where indicated by geographical origin or positive results, serology was performed for schistosomiasis, strongyloidiasis and filarial infection.

Studies screening for multiple infections, excluding NTDs. Two studies screened for multiple infections.^13,27 Both studies performed blood tests for LTBI and BBI. One study¹³ focused on pre-entry screening and included syphilis testing and the use of chest x-ray (CXR) as a screening strategy to rule out active TB.

Studies screening for single infectious disease. All the remaining studies (10/14) described screening strategies with a focus on a single disease. Nine out of 10 focused on TB screening,^{23,26,28–34} with the remainder focusing on hepatitis B.³⁵

Different TB screening strategies were employed. The majority of the studies used interferon- gamma release assay (IGRA) testing, with two of them using additional CXR to detect active TB. Two studies^28,32 screened with only CXR as part of port of entry screening. Three studies described the use of tuberculin skin test (TST) in newly arrived migrants, either in combination with CXR,³¹ exposure history and symptom screening²³ or TST alone.³⁰ Finally, one study in Immigration Detention Centre used a verbal TB screening of symptoms and prior diagnosis.²⁹

Screening settings

Pre-entry screening. Two out of 14 studies described a pre-entry screening practice with migrants screened in their country of origin before reaching the United Kingdom.^13,26

Port of entry screening. A further four studies described screening at the port of entry to the United Kingdom, either at shipping ports^23,32 or airports.²⁸ One study described screening at a hospital as the dedicated location for port of entry screening.³⁰

Screening in primary care in the United Kingdom. Four studies were carried out in primary care settings, with general practitioners being responsible for carrying out the screening.^26,27,33,35

Screening in specialist settings in the United Kingdom. A further four studies were conducted in specialist settings of which two of them are TB clinics^31,34 and two are paediatric infectious diseases clinics.^24,25

Outcomes of infectious diseases screening

Of the studies which considered NTDs as part of their screening, only one study reported positive results. Williams et al.²⁴ reported that 40% of patients screened had an infection identified: 16% schistosomiasis, 8.6% giardiasis, 8% strongyloidiasis and 7% intestinal tapeworm. The other study did not find any patients with schistosomiasis or strongyloidiasis, but the numbers of patients tested were very low (only 4 out of 80; 5%). They reported a 3.7% rate of unexplained eosinophilia that was treated empirically with mebendazole (Harkensee and Andrew).25

As the focus of this review is on screening for NTDs, we have not reported the rates of other infections detected in the studies included in this review. Interpreting these results would be additionally complex as different methodologies were used in each of the studies, uptake of the investigations in the population and the denominator were often not clearly defined, making inter-study comparison difficult.

Qualitative and mixed-methods studies

We included seven studies in the qualitative analysis: six of them had a qualitative design and one was a mixed-method study which included qualitative data from focus groups. Three studies interviewed service users,^25,36,37 and two interviewed service providers.^38,39 One study interviewed migrant health community leads representing a dominant migrant group,⁴⁰ while the final one interviewed key stakeholders with an interest or experience in migrant health.⁴¹

Acceptability among migrants

Screening for infectious diseases in migrant populations has been generally well received in acceptability studies.^36,37

In the Brewin et al.³⁷ study offering screening for TB, the majority of participants reported finding screening reassuring and seeing it as a socially responsible concept.

Similarly, Eborall et al.³⁶ found that an infectious diseases screening programme for LTBI and BBI was both acceptable and beneficial by migrants in a primary care clinic in Leicester. Healthcare leads of a migrant community have also reported that screening was acceptable among migrants provided the services are sufficiently accessible.⁴⁰

Barriers

Multiple barriers to the implementation of screening programmes have been widely reported.^25,38–41 The stigma attached to the diagnosis of certain infectious diseases has been described by both migrants⁴⁰ and healthcare workers.³⁶

Some of the cultural barriers described by service users include staff being ‘culturally insensitive’ and the services not being ‘migrant friendly’.⁴⁰ Asylum-seeking families interviewed by Harkensee and Andrew²⁵ reported a perception of healthcare systems failing to adapt to their needs. Additional barriers to accessing healthcare are fear of deportation,^40,41 not having English as a first language or lack of availability of appropriate translation services,³⁸ lack of information surrounding the entitlement to healthcare as well as a lack of awareness of the relevant services that are provided.⁴⁰

Healthcare workers interviewed in two other studies cited the limited capacity and time constrictions in the National Health Service (NHS) as having a negative impact on the ability of services being able to respond to the needs of refugees and asylum-seekers.^39,41

Facilitators

The importance of community members with lived experience as peer-educators and champions of health promotion have been highlighted in the study by Berrocal-Almanza et al.⁴¹ This is further supported by the linkage of higher acceptability and participation in screening programmes when conducted in community settings or settings where access is easier.^25,40,41

Primary care settings are perceived as being safer for TB screening by a migrant population in London, and screening for infectious diseases was felt to be more acceptable when embedded in a general health check-up⁴⁰ in addition to screening for a broader number of infections.³⁶

Additional structural facilitators such as the availability of more appointments and the presence of translators have been described by asylum-seeking families interviewed.²⁵

Attitude of healthcare workers

Only one study focused on healthcare workers’ attitudes towards infectious diseases screening in the migrant population.³⁸ Only 29% of those surveyed would consider screening a migrant who was newly registered at the practice for BBI and TB. In addition, the majority of primary care staff surveyed (78.9%) reported that they would identify existing migrants for testing opportunistically, rather than inviting them for a routine screening appointment.³⁸

Discussion

Reviewing the existing literature has highlighted that despite disproportionately affecting asylum-seeker and refugee populations,^11,24,42 NTDs are rarely screened for in routine UK practice. Although recommended,²¹ screening is not part of a set of implemented guidelines or NHS regulatory standards, thereby adding barriers to this practice. In the two studies including NTDs screening in their protocols, the testing was selective and targeted, focusing on a limited number of infections: schistosomiasis, strongyloidiasis, filariasis and intestinal parasites.^24,25

There are complex reasons why heterogeneous approaches to screening for NTDs have been adopted. A universal screening programme, by definition, must be able to identify asymptomatic conditions in a target population, using acceptable and cost-effective tests. Interventions should have a clear benefit to the health and well-being of the individuals both directly and indirectly affected.

NTDs can be categorised into three groups based on the feasibility of screening (Table 3). For some NTDs, the principles of screening would not be applicable as they either present symptomatically or are rare, there is no effective treatment or there is no screening test available. For example, dengue, chikungunya and human African trypanosomiasis would present with specific signs and symptoms. Similarly, for rabies and snake bites, in the absence of a history of exposure, there would be no clinical need for screening.

Table 3.

List of neglected tropical diseases subdivided by screening applicability.

Neglected tropical diseases
Screening not recommended	Consider alternative strategy	Screening recommended
DengueChikungunyaHuman African trypanosomiasisRabiesSnakebite envenoming	LeishmaniasisLeprosyLymphatic filariasis Mycetoma, chromoblastomycosis and other deep mycosesOnchocerciasisBuruli ulcerEchinococcosisFoodborne trematodiasesYawsCysticercosisTrachomaScabies and other ectoparasitesGuinea worm disease	Universal: Strongyloidiasis Soil-transmitted helminthiases TaeniasisBased on country of origin: Schistosomiasis Chagas disease

The indication for screening of other NTDs such as leprosy, leishmaniasis, Buruli ulcer, cysticercosis, echinococcosis, filariasis, trachoma and onchocerciasis is not as clear. While these conditions may pose a high risk of morbidity and mortality to the individual, other strategies may be more relevant and cost-effective for the early identification, recognition and treatment of these conditions. Possible alternative interventions are raising awareness among the migrant communities to seek early medical advice and improving the education of both service users and service providers as to the signs and symptoms indicative of NTDs endemic in low- and middle-income countries. Some examples where education of both service users and service providers may be of benefit are new cutaneous ulcers found in a migrant patient should lead to the consideration of leishmaniasis or Buruli ulcer if endemic in their country of origin; new seizures in a patient from rural Peru should ring alarm bells for cysticercosis; anaesthetic, discoloured patches of skin, thickened nerves or nodules as well as loss of eyebrows in patients from India would make leprosy a diagnostic possibility.

For other NTDs such as strongyloidiasis and soil-transmitted helminths, the benefit of screening is undoubtedly relevant. These are relatively common conditions endemic in broad geographical areas, with reliable and reproducible tests and safe and cost-effective interventions. The same is true for both schistosomiasis and Chagas disease if the individuals have lived in endemic countries.

While we have found some evidence of screening for schistosomiasis, strongyloidiasis and soil-transmitted helminths in our review, Chagas disease is not mentioned. One of the reasons is that this disease is geographically circumscribed to Central and South America. Historically, migration from this area has been directed to Southern Europe (mainly Spain, Portugal and Italy); therefore, there may be less awareness among healthcare professionals in the United Kingdom regarding the exposure risks in this population. This has been highlighted by a study conducted out of one of the main specialist centres in the United Kingdom, looking at the delay in diagnosis of Chagas disease. This study showed that a significant proportion of patients had severe, life-threatening complications such as cardiomyopathy at initial presentation to healthcare settings.⁴³ Another study from the same centre showed a low uptake of antenatal screening in pregnant women despite the increased risk of vertical transmission and congenital disease.¹² One potential contributor of this low uptake may be that the Latinx in the United Kingdom are often undocumented, may be living in precarious conditions, and could be marginalised due to a limited command of the English language.⁴⁴ These factors can lead to additional barriers to the access of healthcare services in the United Kingdom. Chagas disease is therefore a good example of how a comprehensive screening programme for Latinx, improved education for healthcare providers as well as raised awareness in the community would be beneficial both for the individual and as a public health intervention.

Two broad approaches to the screening for infectious diseases in migrant populations were identified in this review: targeted screening and panel testing. Panel testing is defined as universal screening regardless of the country of origin, while targeted screening implies testing only for certain NTDs based on risk assessment (i.e. prevalence of the disease in the country of origin or transit). There are pros and cons to both of these strategies. It was generally found that panel testing for infectious diseases and NTDs was a more acceptable approach than testing for single infections. This was especially highlighted when screening was perceived as being part of a general check-up.⁴⁰ This approach also led to a reduction of the stigma attached to screening for certain infections, thus underlining the importance of a holistic approach to the health needs of this vulnerable population.⁴⁰ There are multiple considerations that can be attributed to the perceived benefits of panel testing including the following: reduction in recall bias (the exact geographical locations transited may not be known or remembered accurately), reduction in risk of re-traumatisation of vulnerable individuals (repeated requests to recount the exact journey taken in seeking refuge and asylum) and reduction in appointment length (by removing the need to discuss and document the exact journey taken). However, certain NTDs are only endemic in distinct geographical areas; therefore, panel testing may not only have cost implications but result in less accurate diagnoses. A geographical approach requires a more in-depth knowledge of the epidemiology of infectious diseases by the healthcare provider but will reduce the additional burden placed on specialist parasitology laboratories and reduce the risk of false-positive/cross-reactive serological investigations.

Nonetheless, our review found that in the United Kingdom, there has been a huge heterogeneity of screening strategies, with only 6 out of 16 studies using a broader approach to infectious diseases screening. The majority of the studies focused instead on a single disease, mainly TB. This is consistent with previous research¹⁵ and with surveys of infectious diseases experts.⁴⁵ It may reflect the level of attention given to reducing the burden of TB by policy makers.

The different screening strategies for TB found in the literature review mirror the policy changes in the United Kingdom to tackle active and latent infection in this population. Port of entry screening was abandoned in 2012 and replaced by pre-entry TB screening.¹⁹ There are, however, no strategies that have been developed to try to reach more vulnerable groups of migrants such as those who travel via ‘informal routes’ and remain undocumented.

When looking at screening settings, appointments in primary care and community settings were deemed the most acceptable by the service users.^25,37,40,41 The most likely reasons for this are accessibility, cost of travel and awareness of existing services in addition to the awareness of the rights to access the existing services.²⁵ This highlights the importance of developing health services which are adaptable to the needs of the population. Interestingly, despite outreach interventions having proved to be successful in other socially marginalised groups,^46,47 no study mentioned the use of outreach teams in settings such as contingency accommodation or other non-healthcare community settings.

One of the limitations of our search strategy is the inclusion of studies with a broad concept of ‘migrant’ rather than restricting the search to asylum-seekers and refugees. This is due to the fact that these terms are often used interchangeably in the literature, and focusing on a narrower concept would have risked omission of relevant studies. Only three of the included studies focused specifically on asylum-seekers^23–25 and one on refugees.¹³ The target population of the majority of the studies was newly arrived migrants, without distinction on their ‘status’. We recognise it may be difficult to characterise these distinct populations given the political implication of the legal status/right to remain. However, we believe that identification of the different sub-population of migrants is likely to be of benefit to them. This would allow for services to flexibly meet their specific health and social care needs. While asylum-seekers and refugees are often complex and highly vulnerable individuals, the majority of migrants to the United Kingdom move from high-income settings with a high educational level and standard of living. In addition to this, the ‘healthy migrant effect’ is often seen, whereby new arrivals to a country have a reduced burden of both communicable and non-communicable diseases when compared with the general population of the host nation.^48,49

This review has highlighted the lack of evidence around infectious diseases screening strategies focusing on asylum-seekers and refugees. The paucity of data addressing the uptake of screening programmes, the effectiveness of different screening strategies and lack of outcome measures of the screening add to the challenges faced by healthcare professionals and policy makers. It is therefore not feasible at present to make generalisable recommendations for panel-based NTD screening. Additional research would be of benefit to try to address this gap in knowledge.

When planning screening interventions, priority should be given to the identification of outreach settings (such as hotels or migrant community centres), community engagement and using peer support workers. More attention should be placed on the identification of sub-groups of the migrant population thus allowing more focus to be given to specific needs within these groups.

On balance, we recommend that screening for some NTDs alongside broader infectious diseases screening is considered as part of a comprehensive health assessment of this population. We believe that this strategy would contribute to lowering the stigma associated with the diagnosis of certain diseases and increasing screening acceptability.

Ultimately, screening policies should aim to overcome the barriers in accessing healthcare for these vulnerable populations, providing early recognition and treatment of diseases with potential long-term consequences to health and well-being.

Supplemental Material

sj-doc-2-tai-10.1177_20499361221116680 – Supplemental material for Screening for neglected tropical diseases and other infections in refugee and asylum-seeker populations in the United Kingdom

Supplemental material, sj-doc-2-tai-10.1177_20499361221116680 for Screening for neglected tropical diseases and other infections in refugee and asylum-seeker populations in the United Kingdom by Paola Cinardo, Olivia Farrant, Kimberlee Gunn, Allison Ward, Sarah Eisen and Nicky Longley in Therapeutic Advances in Infectious Disease

Supplemental Material

sj-doc-3-tai-10.1177_20499361221116680 – Supplemental material for Screening for neglected tropical diseases and other infections in refugee and asylum-seeker populations in the United Kingdom

Supplemental material, sj-doc-3-tai-10.1177_20499361221116680 for Screening for neglected tropical diseases and other infections in refugee and asylum-seeker populations in the United Kingdom by Paola Cinardo, Olivia Farrant, Kimberlee Gunn, Allison Ward, Sarah Eisen and Nicky Longley in Therapeutic Advances in Infectious Disease

Supplemental Material

sj-docx-1-tai-10.1177_20499361221116680 – Supplemental material for Screening for neglected tropical diseases and other infections in refugee and asylum-seeker populations in the United Kingdom

Supplemental material, sj-docx-1-tai-10.1177_20499361221116680 for Screening for neglected tropical diseases and other infections in refugee and asylum-seeker populations in the United Kingdom by Paola Cinardo, Olivia Farrant, Kimberlee Gunn, Allison Ward, Sarah Eisen and Nicky Longley in Therapeutic Advances in Infectious Disease

Supplemental Material

sj-docx-4-tai-10.1177_20499361221116680 – Supplemental material for Screening for neglected tropical diseases and other infections in refugee and asylum-seeker populations in the United Kingdom

Supplemental material, sj-docx-4-tai-10.1177_20499361221116680 for Screening for neglected tropical diseases and other infections in refugee and asylum-seeker populations in the United Kingdom by Paola Cinardo, Olivia Farrant, Kimberlee Gunn, Allison Ward, Sarah Eisen and Nicky Longley in Therapeutic Advances in Infectious Disease

Footnotes

Acknowledgements

Not applicable.

Declarations

ORCID iD

Paola Cinardo

Supplemental material

Supplemental material for this article is available online.

References

Department of Economic and Social Affairs, United Nations. International migration report 2013, https://www.un.org/en/development/desa/population/publications/pdf/migration/migrationreport2013/Full_Document_final.pdf

Forced migration or displacement. Migration Data Portal, https://www.migrationdataportal.org/themes/forced-migration-or-displacement (accessed 18 May 2022).

Sturge

Asylum statistics. London: House of Commons Library, https://researchbriefings.files.parliament.uk/documents/SN01403/SN01403.pdf (accessed 16 July 2021).

United Nations High Commissioner for Refugees. Asylum in the UK, https://www.unhcr.org/uk/asylum-in-the-uk.html (accessed 13 March 2022).

Neglected tropical diseases – GLOBAL, https://www.who.int/health-topics/neglected-tropical-diseases (accessed 22 June 2022).

Engels

Zhou

X-N.

Neglected tropical diseases: an effective global response to local poverty-related disease priorities. Infect Dis Poverty 2020; 9: 10.

Indicator 3.3.5 – number of people requiring interventions against neglected tropical diseases. U.K. Indicators for the Sustainable Development Goals, https://sdgdata.gov.uk/3-3-5/ (accessed 23 June 2022).

Dengue fever: guidance, data and analysis. GOV.UK, https://www.gov.uk/government/collections/dengue-fever-guidance-data-and-analysis (2008, accessed 23 June 2022).

Chikungunya. GOV.UK, https://www.gov.uk/guidance/chikungunya (accessed 23 June 2022).

10.

Rabies: epidemiology, transmission and prevention. GOV.UK, https://www.gov.uk/guidance/rabies-epidemiology-transmission-and-prevention (accessed 23 June 2022).

11.

Martelli

Di Girolamo

Zammarchi

, et al. Seroprevalence of five neglected parasitic diseases among immigrants accessing five infectious and tropical diseases units in Italy: a cross-sectional study. Clin Microbiol Infect 2017; 23: 335.e1–335.e5.

12.

Fernandez Turienzo

Cabeza Brasa

Newsholme

, et al. Chagas disease among pregnant Latin American women in the United Kingdom: time for action. BMJ Glob Health 2017; 2: e000478.

13.

Crawshaw

Pareek

Were

, et al. Infectious disease testing of UK-bound refugees: a population-based, cross-sectional study. BMC Med 2018; 16: 143.

14.

Eziefula

Brown

The health of recent migrants from resource-poor countries. Medicine 2010; 38: 60–65.

15.

Seedat

Hargreaves

Nellums

, et al. How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review. Lancet Infect Dis 2018; 18: e259–e271.

16.

Warren

(Re)locating the border: pre-entry tuberculosis (TB) screening of migrants to the UK. Geoforum 2013; 48: 156–164.

17.

Tunbridge

Chapman

MacFarlane

, et al. Improving infection screening for international immigrants Anne J Tunbridge, Joan Macfarlane, Julie Mather, Ann LN Chapman category: lesson in microbiology & infection control. J Infect 2011; 63: e32–e33.

18.

Department of Health. Stopping tuberculosis in England, an action plan from the Chief Medical Office, 2004, https://www.tbalert.org/wp-content/uploads/2011/04/images_pdf_stoppingtb_actionplan.pdf

19.

UK Home Office. Pre-entry tuberculosis screening under immigration powers, 2012, https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/117947/policy-statement-statement.pdf

20.

Home Office, Public Health England, International Organization for Migration. Health protocol pre-entry health assessments for UK-Bound Refugees, 2020, https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/892799/Badged_HA_protocol_IOM_HO_PHE_-_June_2020.odt.pdf

21.

Office for Health Improvement and Disparities. Migrant health guide. GOV.UK, https://www.gov.uk/government/collections/migrant-health-guide (2021, accessed 31 March 2022).

22.

Royal College of Paediatrics and Child Health, Protection Standing Committee and the Advocacy Committee. Refugee and unaccompanied asylum-seeking children and young people – guidance for paediatricians, https://www.rcpch.ac.uk/sites/default/files/generated-pdf/document/Refugee-and-unaccompanied-asylum-seeking-children-and-young-people—guidance-for-paediatricians.pdf (accessed 2 February 2022).

23.

Harling

Pearce

Chandrakumar

, et al. Tuberculosis screening of asylum seekers: 1 years’ experience at the Dover Induction Centres. Public Health 2007; 121: 822–827.

24.

Williams

Boullier

Cricks

, et al. Screening for infection in unaccompanied asylum-seeking children and young people. Arch Dis Child 2020; 105: 530–532.

25.

Harkensee

Andrew

Health needs of accompanied refugee and asylum-seeking children in a UK specialist clinic. Acta Paediatr 2021; 110: 2396–2404.

26.

Berrocal-Almanza

Harris

Lalor

, et al. Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort study. Lancet Infect Dis 2019; 19: 1191–1201.

27.

Hargreaves

Seedat

Car

, et al. Screening for latent TB, HIV, and hepatitis B/C in new migrants in a high prevalence area of London, UK: a cross-sectional study. BMC Infect Dis 2014; 14: 657.

28.

Severi

Maguire

Ihekweazu

, et al. Outcomes analysis of new entrant screening for active tuberculosis in Heathrow and Gatwick airports, United Kingdom 2009/2010. BMC Infect Dis 2016; 16: 178.

29.

McLaren

Baugh

Plugge

, et al. Describing the burden of infectious diseases among a population of detainees in an Immigration Removal Centre (IRC) in the United Kingdom: a descriptive epidemiological approach. J Immigr Minor Health 2013; 15: 764–770.

30.

Bothamley

Rowan

Griffiths

, et al. Screening for tuberculosis: the port of arrival scheme compared with screening in general practice and the homeless. Thorax 2002; 57: 45–49.

31.

Underwood

White

VLC

Baker

, et al. Contact tracing and population screening for tuberculosis – who should be assessed? J Public Health Med 2003; 25: 59–61.

32.

Millership

Cummins

Identification of tuberculosis cases by port health screening in Essex 1997-2003. J Public Health 2005; 27: 196–198.

33.

Loutet

Burman

Jayasekera

, et al. National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area. Eur Respir J 2018; 51: 1701226.

34.

Pareek

Lalvani

Watson

, et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis 2011; 11: 435–444.

35.

Evlampidou

Hickman

Irish

, et al. Low hepatitis B testing among migrants: a cross-sectional study in a UK city. Br J Gen Pract 2016; 66: e382–e391.

36.

Eborall

Wobi

Ellis

, et al. Integrated screening of migrants for multiple infectious diseases: qualitative study of a city-wide programme. EClinicalMedicine 2020; 21: 100315.

37.

Brewin

Jones

Kelly

, et al. Is screening for tuberculosis acceptable to immigrants? A qualitative study. J Public Health 2006; 28: 253–260.

38.

Roche

Simmons

Crawshaw

, et al. What do primary care staff know and do about blood borne virus testing and care for migrant patients? A national survey. BMC Public Health 2021; 21: 336.

39.

Hogan

Coker

Gordon

, et al. Screening of new entrants for tuberculosis: responses to port notifications. J Public Health 2005; 27: 192–195.

40.

Seedat

Hargreaves

Friedland

JS.

Engaging new migrants in infectious disease screening: a qualitative semi-structured interview study of UK migrant community health-care leads. PLoS ONE 2014; 9: e108261.

41.

Berrocal-Almanza

Botticello

Piotrowski

, et al. Engaging with civil society to improve access to LTBI screening for new migrants in England: a qualitative study. Int J Tuberc Lung Dis 2019; 23: 563–570.

42.

Clark

Mytton

Estimating infectious disease in UK asylum seekers and refugees: a systematic review of prevalence studies. J Public Health 2007; 29: 420–428.

43.

González Sanz

De Sario

García-Mingo

, et al. Chagas disease in the United Kingdom: a review of cases at the Hospital for Tropical Diseases London 1995-2018. The current state of detection of Chagas disease in the UK. Travel Med Infect Dis 2020; 36: 101760.

44.

Román-Velázquez

Retis

Latin American immigration to Europe: the case of London. In: Román-Velázquez

Retis

(eds) Narratives of migration, relocation and belonging: Latin Americans in London. Cham: Springer, 2021, pp. 31–62.

45.

Karki

Napoli

Riccardo

, et al. Screening for infectious diseases among newly arrived migrants in EU/EEA countries – varying practices but consensus on the utility of screening. Int J Environ Res Public Health 2014; 11: 11004–11014.

46.

Olivet

Bassuk

Elstad

, et al. Outreach and engagement in homeless services: a review of the literature. Open Health Serv Policy J 2010; 3: 53–70.

47.

Jit

Stagg

Aldridge

, et al. Dedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluation. BMJ 2011; 343: d5376.

48.

Rubalcava

Teruel

Thomas

, et al. The healthy migrant effect: new findings from the Mexican Family Life Survey. Am J Public Health 2008; 98: 78–84.

49.

Aldridge

Nellums

Bartlett

, et al. Global patterns of mortality in international migrants: a systematic review and meta-analysis. Lancet 2018; 392: 2553–2566.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.05 MB

0.04 MB

0.02 MB